Democrats Target Deals to Delay Generics
As part of its drive to cut health-care costs, the Obama administration wants to stop the payments pharmaceutical companies make to generic-drug makers to delay the launch of cheap copies.
Wall Street Journal, 31/3/9
http://online.wsj.com/article/SB123843757514670479.html